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ABSTRACT 
Objective: We herein report the simultaneous trace level determination of benzene and 1,2-dichloroethane in several active pharmaceutical 
substances by GC-HS (gas chromatograph-head space) using a DB-624 column.  
Methods: This GC-HS method was developed based on an oven-programmed approach using nitrogen gas as the mobile phase. Our method is also 
compatible with the GC-MS (gas chromatography-mass spectrometry) technique using helium as the mobile phase instead of nitrogen. The 
successful separation of benzene and 1,2-dichloroethane was established by confirmation of their corresponding specific molecular masses. 
Results: The retention time of benzene and 1,2-dichloroethane were found to be 34.8 min and 35.6 min, respectively. The linearity was found in the 
range of concentration of 0.63-4.22 ppm and 1.49-9.96 ppm for benzene and 1,2-dichloroethane. The detection limit and quantification limit for 
benzene were 0.2 and 0.6 ppm, while those of 1,2-dichloroethane were 0.6 ppm and 1.5 ppm. These values were calculated using our developed 
method with respect to the test concentration of 500 mg/ml. The recovery of benzene and 1,2-dichloroethane were found to be 89–110% and 91–
105%, respectively for the various pharmaceutical drug substances. The specificity of the method was studied using 20 solvents which include 
benzene and 1,2-dichloroethane. 
Conclusion: We expect that our method will be applicable for the simultaneous trace level determination of benzene and 1,2-dichloroethane during 
the control of manufacturing processes, and for use in rapid analysis for quality control in the pharmaceutical industry. Finally, this method was 
validated according to the International Conference on Harmonization (ICH) Validation Guidelines Q2 (R1). 
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Benzene (fig. 1) is known to cause central nervous system depression in 
addition to destroying bone marrow, which in turn leads to damage to 
the hematopoietic system. In addition, benzene has been demonstrated 
to be a human carcinogen (i.e., lymphatic and hematopoietic cancers), 
while in animal studies, Zymbal gland tumors, preputial gland tumors, 
skin carcinomas, mammary gland tumors, and leukemia have been 
reported. Although positive chromosomal aberration and DNA adducts 
tests have been recorded, the results of other mutagenicity tests were 
negative. From the data of human leukemia and benzene exposure 
correlations, a daily intake of 0.02 mg was found to be associated with a 
lifetime excess cancer risk of 10−5
Repeated exposure to 1,2-dichloroethane (fig. 1) has been reported 
to induce, nausea, abdominal pain, irritation of mucous membranes, 
dysfunction of liver and kidney and neurological disorders. In 
addition, the depression of leukocytes, antibody-forming cells, and 
cellular immunity was also found in mice, while necrosis of the 
cerebellum and hyperplasia was observed in addition to 
inflammation of the forestomach in male rats after oral 
administration. Although there is no evidence of carcinogenicity in 
humans, forestomach cancer, hemangiosarcoma, breast cancer, 
uterine cancer, and respiratory tract cancer were found in rats and 
mice following gavage treatment. The evidence reported to date, 
therefore, indicates that 1,2-dichloroethane is potentially genotoxic, 
and excess cancer risk of 10
 (IRIS), and we note that the guideline 
value for benzene is 0.02 mg/d (2 ppm) [1−5]. 
−5
To date, the detection and quantification of benzene and 1,2-
dichloroethane have been using only gas chromatography-mass 
spectrometry (GC-MS) techniques [6-28]. However, previous reports 
in this area focus on the analysis of the benzene and do not address 
the detection or quantification of 1,2-dichlorethane.  
 was reported at exposures of 0.05 
mg/d for 50 kg human based on hemangiosarcoma using a 
linearized multistage model without body surface correction. The 
guideline value for 1,2-dichloroethane is 0.05 mg/d (5 ppm) [1−5].  
Indeed, the simultaneous trace level determination of benzene and 
1,2-dichloroethane in pharmaceutical drug substances has yet to be 
reported, and so we selected gas chromatography-head space (GC-
HS) technique for the purpose of our study in combination with a 
DB-624 capillary column for the determination of these two 






Fig. 1: Chemical structures of benzene and 1,2-dichloroethane 
 
MATERIALS AND METHODS 
Materials 
All samples (i.e., Cabergoline, Celecoxib, Dronedarone hydrochloride, 
Etravirine, Fesoterodine fumarate, Gabapentin, Irinotecan 
hydrochloride, Levetricetam and Levothyroxine sodium with the 
purity of 95%) were received from Jinan Jiage Biological Technology 
Co, Ltd., China. Benzene, 1,2-dichloroethane, dimethyl sulfoxide, n-
butyl acetate, methanol, ethanol, acetone, isopropyl alcohol, 
acetonitrile, dichloromethane, n-hexane, ethyl acetate, 
tetrahydrofuran, toluene, n-heptane, 2-butanone, cyclohexane, 
methyl tertiary butyl ether, methyl isobutyl ketone and diisopropyl 
ether solvents were purchased from Fisher Scientific with the purity 
of 99.5% (Mumbai, India). The DB-624 GC capillary column was 
obtained from LCGC (Hyderabad, India). USP grade water was 
employed throughout and was prepared using a Metrohm Elga 
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water purifier (Metrohm, Switzerland). The nitrogen gas cylinder 
was procured from Indo Gas agencies (Tamil Nadu, India). 
Development and validation studies were carried out using an 
Agilent 7890A GC equipped with a G1888 headspace sampler 
(Agilent Technologies, Singapore). Finally, an Agilent 5973C GC-MS 
(Agilent technologies, Singapore) was utilized for molecular mass 
identification of the benzene and 1,2-dichloroethane peaks. 
Solution preparation 
Preparation of internal standard solution  
The internal standard (IS) solution was prepared by dissolving n-
butyl acetate (50 mg) in dimethyl sulfoxide (50 ml).  
Preparation of diluent 
The diluent was prepared by mixing dimethyl sulfoxide (700 ml) 
with water (300 ml), followed by the addition of IS solution (2.5 ml). 
The resulting solution was allowed to cool to 25 °C.  
Preparation of standard stock solution  
The standard stock solution was prepared by diluting benzene (50 
mg) and 1,2-dichloroethane (125 mg) in the diluent (50 ml). 5 ml 
portion of this solution was then diluted further to 100 ml using the 
diluent.  
Preparation of standard solution  
The standard solution was then prepared by diluting a portion of the 
standard stock solution (2 ml) to a final volume of 100 ml using the 
diluent. The concentrations of benzene and 1,2-dichloroethane in 
the standard solution were 2.0 ppm and 5.0 ppm respectively, with 
respect to the analyte concentration.  
Preparation of sample solution  
The sample solution was prepared by dilution of sample (1000 mg) 
in the diluent (2 ml) in a headspace vial. For the preparation of the 
spiked sample solutions, the sample (1000 mg) was weighed in a 
headspace vial, and the standard solution was added for (2 ml). 
Method 
GC chromatographic conditions 
A DB-624 (60 m × 0.32 mm × 1.8 µm) column was employed for GC 
analysis. The oven temperature program began with an initial 
temperature about 35 °C (hold time = 45 min), Followed by heating 
to 240 °C at a rate of 30 °C/min, and holding at this final 
temperature for 25 min. The total run time was 76.83 min, a split 
injection mode with a split ratio of 5: 1 was used, and the column 
flow rate was 1.5 ml/min. The injection port and detector 
temperatures were both set at 240 °C.  
HS Chromatographic conditions 
In terms of the HS conditions, the oven temperature was 110 °C, 
loop temperature was 175 °C, and the transfer line temperature was 
175 °C. A cycle time of 85 min was employed, along with vial 
equilibration time of 60 min, a vial pressurization time of 1 min, a 
loop filling time of 0.5 min, a loop equilibration time of 0.5 min, and 
an injection time of 1 min. The vial pressure was maintained at 15 
psi.  
Other general chromatographic conditions 
Nitrogen and helium were used as the mobile phase for GC-HS and 
GC-MS analysis respectively. All other parameters were as described 
for GC-HS above. Each headspace vial was closed tightly with PTFE 
septum and sealed by the crimping of an aluminium cap. The vials 
were introduced into the chromatograph using a headspace auto 
sampler. For the specificity study, desired solvent (10−20 mg) was 
added to a headspace vial with the diluent. Each solvent vial was 
closed tightly with PTFE septum and sealed by the crimping of an 
aluminium cap. The chromatograms of the blank and standard 
solutions are shown in fig. 2. 
 
 
Fig. 2: Chromatograms of (a) the blank and (b) the standard solutions 
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RESULTS AND DISCUSSION 
Development 
In recent years, several trials have been performed involving the 
investigation of different capillary stationary phases for the 
detection of benzene [6-28]. However, we selected the DB-624 
capillary column as the stationary phase for our study due to its 
unique properties. The selection of pharmaceutical drug substances 
was based on the availability and cost. In addition, the solvents 
employed for the specificity study were selected based on the 
reported synthetic process of their respective product patents. 
The resolution of<0.8 was obtained between benzene and 1,2-
dichloroethane using 20 and 30 m capillary GC columns. As the boiling 
points of benzene and 1,2-dichloroethane are similar. (i.e., 80.1 °C and 
83.5 °C, respectively), increasing the column length was expected to 
improve the resolution. Thus, a column measuring 60 m in length with 
an internal diameter of 0.32 mm and a particle size of 1.8 µm was 
employed.  
Validation 
The system suitability and precision, limit of detection (LOD), limit 
of quantitation (LOQ), linearity and range, recovery, specificity, 
robustness, and solution stability of this method for the analysis of 
benzene and 1,2-dichloroethane were determined as per the ICH 
validation guidelines Q2, (R1) [29]. Further details regarding each of 
the above points can be found in the following subsections. 
System suitability and precision 
As indicated in table 1, a resolution of 1.9 was established between 
the benzene and 1,2-dichloroethane upon analysis of the standard 
solution under the optimized conditions. To determine the precision 
of this analytical system (i.e., an expression of the closeness of 
agreement between a series of measurements obtained from 
multiple sampling of the same homogeneous sample under the 
prescribed conditions) [29], the standard solution was injected into 
the chromatograph six times and the percentage relative standard 
deviation (%RSD) was calculated. The obtained %RSD of<3% 
indicates that this system was precise (%RSD limit = ≤15%) [29], 
and as such, is suitable for analysis of the benzene and 1,2-
dichloroethane contents. Further details regarding determination of 
the system precision are outlined in table 1 below. 
Method precision 
To determine the precision of this method, six spiked sample 
solutions were initially prepared. Using the above-described 
method, the % RSD for the benzene and 1, 2-dichloroethane content 
were<0.5% for the method precision (limit =<5%) [29], and these 
values were within 1.0% for the intermediate precision when 
performed by different analysts, on different columns and 
instruments on different days. These observations, in combination 
with the detailed results outlined in table 2, indicate that our 
developed technique was suitably precise for the system of interest. 
 
Table 1: Determination of the system suitability of % RSD along with resolution and precision for benzene and 1,2-dichloroethane 
%RSD of peak area ratios 
Inj. # Benzene 1,2-Dichloroethane Criteria 
1 0.5394 0.2351 ≤15% 
2 0.5414 0.2335 
3 0.5464 0.2393 
4 0.5481 0.2437 
5 0.5401 0.2472 
6 0.5471 0.2413 
Mean 0.5437 0.2400 
SD 0.00 0.01 
%RSD 0.71 2.16 
Inj. # Resolution Criteria 
1 1.9 ≥1.2 
*Abbreviations: Each value is represented as the mean+SD of 6 measurements (n = 6), SD: standard deviation, RSD: relative standard deviation, # 
Acceptance criteria<15%. 
 
Table 2: Method and intermediate precision results for benzene and 1,2-dichloroethane 
Preparation No. Benzene content (ppm) 1,2-Dichloroethane content (ppm) 
1 2.145 5.151 
2 2.147 5.152 
3 2.149 5.150 
4 2.150 5.153 
5 2.150 5.149 
6 2.151 5.148 
Mean 2.148 5.150 
SD 0.00 0.00 
%RSD 0.10 0.03 
1 2.105 5.056 
2 2.107 5.025 
3 2.140 5.015 
4 2.102 5.006 
5 2.109 4.998 
6 2.114 5.015 
Mean 2.112 5.019 
SD 0.01 0.02 
%RSD 0.65 0.40 
*Abbreviations: Each value is represented as the mean+SD of 6 measurements (n = 6), SD: standard deviation, RSD: relative standard deviation, # 
Acceptance criteria<5%.  
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Limit of detection and limit of quantification 
The method detection limit (MDL) and method quantification limit 
(MQL) (i.e., the LOD and the LOQ) were determined based on the 
signal to noise (S/N) ratio method as outlined in the ICH guideline 
Q2 (R1). Upon injecting the solution sequence of predetermined 
known concentrations (0.1−2.5 ppm for benzene and 0.5−5.5 ppm 
for 1,2-dichloroethane), the S/N ratio for the LOD was determined to 
be 3:1, while that of the LOQ was determined to be 10:1. Thus, the 
MDL for benzene and 1,2-dichloroethane were 0.2 and 0.5 ppm, 
respectively; the MQL for benzene and 1,2-dichloroethane were 0.6 
and 1.5 ppm, respectively. These results indicate that our method 
was sufficiently sensitive for simultaneous trace level determination 
of the benzene and 1,2-dichloroethane contents in the of 
pharmaceutical drug substances examined herein. 
Linearity and range 
The linearity of an analytical procedure reflects its ability to produce 
results that are directly proportional to the concentration of an 
analyte in the sample [29]. In this case, linearity tests were 
performed from the LOQ to 200% of this limit for an analyte 
concentration. The results of this test and the corresponding 
correlation coefficients are shown in table 3, while the linearity plots 
are provided in fig. 3 and 4. As shown, the correlation coefficient was 
close to 1, indicating that the developed method was indeed linear. 
Furthermore, the statistical linear regression results indicate that 
the validated method was linear for pharmaceutical drug substances 
examined herein, and that this linearity was satisfactory over the 
defined concentration range (i.e., 0.6–4.2 ppm for benzene and 
1.5−9.9 ppm for 1,2-dichloroethane). 
 
 
Fig. 3: The linearity plot for benzene 
 
 
Fig. 4: The linearity plot for 1,2-dichloroethane
Table 3: Linearity data for benzene and 1,2-dichloroethane 
Benzene 
Sample No. % Level Concentration (ppm) Area ratio 
1 LOQ 0.63 0.1808 
2 40 0.84 0.2595 
3 80 1.69 0.4645 
4 100 2.11 0.5517 
5 120 2.53 0.6581 
6 160 3.38 0.8772 
7 200 4.22 1.0761 
Slope 0.246 
Y-intercept 0.0386 
Correlation co-efficient squared (r2 0.9991 ) 
1,2-Dichloroethane 
Sample No. % Level Concentration (ppm) Area ratio 
1 LOQ 1.49 0.0756 
2 40 1.99 0.1002 
3 80 3.98 0.1954 
4 100 4.98 0.2458 
5 120 5.97 0.2988 
6 160 7.97 0.3863 
7 200 9.96 0.4626 
Slope 0.0464 
Y-intercept 0.011 
Correlation co-efficient squared (r2 0.9975 ) 




The accuracy of an analytical procedure indicates the closeness of 
understanding between the quality which is acknowledged either as 
a true conventional value or an accepted reference value and the 
value found [29]. For quantitative approaches, a minimum of nine 
determinations across a specified range should be obtained [29]. In 
our case, the accuracy (%) for detecting the benzene and 1, 2-
dichloroethane in LOQ and in 50%, 100% and 150% levels for the 
various pharmaceutical drug substances were 89–110% and 91–
105%, respectively. These results indicate that our developed 
method was accurate for the present analytical system, as the mean 
accuracy value was within the standard 80–120% limit.  
Furthermore, the accuracy of this method at the LOQ and at 50, 100, 
and 150% levels of benzene and 1, 2-dichloroethane is outlined in 
tables 4 and 5. 
Specificity 
Specificity is the ability to assess the analyte unequivocally in the 
presence of other components that may be present in the mixture. These 
may typically include solvents, impurities, degradants, and matrix 
components, among others [29]. Thus, the specificity of our method was 
determined by examination of the interference. No interference was 
observed either from the blank or from all solvents. Furthermore, the 
solvent spiking results (i.e., with sample spiking) indicate that benzene 
Sultana et al. 
Int J App Pharm, Vol 11, Issue 1, 2019, 82-88 
 
86 
and 1, 2-dichloroethane were not co-eluted with the other solvents. 
These results confirm the specificity/homogeneity of our developed 
method for the detection of benzene and 1, 2-dichloroethane. This was 
also confirmed by GC-MS, and the mass spectra are given in fig. 5 and 6. 
 
Table 4: Accuracy of this method for the detection of benzene in various pharmaceutical drug substances (% recovery) 
Pharmaceutical drug substance LOQ 50% 100% 150% 
Cabergoline 89% 92% 91% 101% 
Celecoxib 92% 95% 89% 93% 
Dronedarone hydrochloride 93% 95% 100% 90% 
Etravirine 96% 97% 105% 99% 
Etoricoxib 97% 96% 98% 98% 
Fesoterodine fumarate 98% 93% 96% 95% 
Gabapentin 101% 92% 93% 99% 
Irinotecan hydrochloride 98% 91% 89% 102% 
Levetricetam 95% 94% 102% 101% 
Levothroxine sodium  93% 89% 101% 110% 
*Abbreviations: Each value is an average of 10 measurements (drugs) (n = 10), LOQ: limit of quantitation, # Acceptance criteria 80-120%.  
 
 
Fig. 5: The mass spectrum of benzene 
 
 
Fig. 6: The mass spectrum of 1,2-dichloroethane 
 
Robustness 
We then examined the effect of chromatographic conditions on the 
resolution between the benzene and 1,2-dichloroethane. As the 
original nitrogen gas flow rate was 1.5 ml/min, we varied the flow 
rate from 1.4 to 1.6 ml/min to investigate its effect on the resolution. 
In addition, the column oven temperature was set at 30, 35, or 40 °C 
to examine the effect of temperature.  
Finally, the headspace oven temperature was varied between 100 
and120 °C. Interestingly, the resolution was>1.0 under all conditions 
studied, thus demonstrating the robustness of our method. 
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Table 5: Accuracy of this method for the detection of 1,2-dichloroethane in various pharmaceutical drug substances (% recovery) 
Pharmaceutical drug substance LOQ 50% 100% 150% 
Cabergoline 91% 96% 97% 101% 
Celecoxib 102% 100% 101% 98% 
Dronedarone hydrochloride 98% 98% 102% 105% 
Etravirine 88% 95% 93% 98% 
Etoricoxib 91% 97% 100% 102% 
Fesoterodine fumarate 95% 102% 100% 101% 
Gabapentin 101% 102% 103% 100% 
Irinotecan hydrochloride 98% 97% 101% 99% 
Levetricetam 92% 101% 103% 98% 
Levothroxine sodium  97% 99% 98% 100% 
*Abbreviations: Each value is an average of 10 measurements (drugs) (n = 10), LOQ: limit of quantitation, # Acceptance criteria 80-120%.  
 
Solution stability 
Finally, the solution stability was determined by examination of a 
freshly prepared standard solution in a sealed vial at 25 °C over 24 h. 
The % Difference between the peak areas of benzene and 1,2-
dichloroethane at 0 h and 24 h<15% for standard solution [29]. The 
obtained results thereby confirm that the standard solution was 
stable under these conditions. 
CONCLUSION 
We herein reported the versatile gas chromatographic method for 
the simultaneous quantitative determination and separation of 
benzene and 1,2-dichloroethane in pharmaceutical drug substances. 
More specifically, a DB-624 column was employed in our precise and 
accurate method, yielding acceptable and repeatable recoveries in 
addition to low limits of detection and quantification. This 
authenticated method is expected to be applicable in the regular 
analysis of benzene and 1,2-dichloroethane in quality control 
laboratories of pharmaceutical drug substances. However, further 
studies are required to decrease the run time of our method, as this 
was not possible through simply increasing the column flow rate. 
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